On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Kansai Medical University

InstitutionResearch output, impact & collaborations

Kansai Medical University is a institution indexed in ScholarIQ from OpenAlex.

What is known about Kansai Medical University?

ScholarIQrecord summary

Kansai Medical University is a research organisation in Osaka, JP. OpenAlex records 18,102 works and 1,214,443 citations for it. 4,151 researchers list it as their most recent affiliation.

How many works does Kansai Medical University have?

ScholarIQindexed works

Kansai Medical University has 18,102 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Kansai Medical University have?

ScholarIQcitation count

Kansai Medical University has 1,214,443 citations in the OpenAlex counts ScholarIQ stores.

How many researchers are at Kansai Medical University?

ScholarIQresearcher count

Kansai Medical University has 4,151 researchers in the ScholarIQ index.

What is the average h-index at Kansai Medical University?

ScholarIQavg h-index

Kansai Medical University has an average h-index of 59.1 in OpenAlex.

What is the ROR of Kansai Medical University?

ScholarIQror

The ROR for Kansai Medical University is on the source record.

What is the OpenAlex record for Kansai Medical University?

ScholarIQopenalex

The OpenAlex for Kansai Medical University is on the source record.

Who are the most-cited researchers behind Kansai Medical University?

ScholarIQtop researchers by citations
1
Hiroshi Ohno · Gut microbiota and health
587 works39,287 citations
2
Kazuichi Okazaki · IgG4-Related and Inflammatory Diseases
868 works39,120 citations
3
Takayasu Kurata · Lung Cancer Treatments and Mutations
457 works36,452 citations
4
Kenichi Yoshida · Acute Myeloid Leukemia Research
890 works34,021 citations
5
Carlotta Giorgi · Mitochondrial Function and Pathology
250 works26,111 citations

What are the most-cited papers on Kansai Medical University?

ScholarIQmost cited works
Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer
Leena Gandhi, Delvys Rodríguez‐Abreu, Shirish M. Gadgeel, Emilio Esteban, Enriqueta Felip, Flávia De Angelis, Manuel Dómine, Philip R. Clingan, Maximilian J. Hochmair, Steven Powell, Susanna Y. Cheng, Helge Bischoff, Nir Peled, Francesco Grossi, Ross Jennens, Martin Reck, Rina Hui, Edward B. Garon, Michael Boyer, Belén Rubio‐Viqueira, Silvia Novello, Takayasu Kurata, Jhanelle E. Gray, John Vida, Ziwen Wei, Jing Yang, Harry Raftopoulos, M. Catherine Pietanza, Marina Chiara Garassino
New England Journal of Medicine. 20186,696 CitationsOPEN ACCESS
Osimertinib in Untreated <i>EGFR</i> -Mutated Advanced Non–Small-Cell Lung Cancer
Jean‐Charles Soria, Yuichiro Ohe, Johan Vansteenkiste, Thanyanan Reungwetwattana, Busyamas Chewaskulyong, Ki Hyeong Lee, Arunee Dechaphunkul, Fumio Imamura, Naoyuki Nogami, Takayasu Kurata, Isamu Okamoto, Caicun Zhou, Byoung Chul Cho, Ying Cheng, Eun Kyung Cho, Pei Jye Voon, David Planchard, Wu‐Chou Su, Jhanelle E. Gray, Siow Ming Lee, Rachel Hodge, Marcelo Marotti, Yuri Rukazenkov, Suresh S. Ramalingam
New England Journal of Medicine. 20175,376 CitationsOPEN ACCESS
Overall Survival with Osimertinib in Untreated, <i>EGFR</i> -Mutated Advanced NSCLC
Suresh S. Ramalingam, Johan Vansteenkiste, David Planchard, Byoung Chul Cho, Jhanelle E. Gray, Yuichiro Ohe, Caicun Zhou, Thanyanan Reungwetwattana, Ying Cheng, Busyamas Chewaskulyong, Riyaz Shah, Manuel Cobo, Ki Hyeong Lee, Parneet Cheema, Marcello Tiseo, Thomas John, Meng‐Chih Lin, Fumio Imamura, Takayasu Kurata, Alexander Todd, Rachel Hodge, Matilde Saggese, Yuri Rukazenkov, Jean‐Charles Soria
New England Journal of Medicine. 20192,875 CitationsOPEN ACCESS
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC
Scott Antonia, Augusto Villegas, Davey B. Daniel, David Vicente, Shuji Murakami, Rina Hui, Takayasu Kurata, Alberto Chiappori, Ki Hyeong Lee, Maike de Wit, Byoung Chul Cho, Maryam Bourhaba, Xavier Quantin, Takaaki Tokito, Tarek Mekhail, David Planchard, Young‐Chul Kim, Christos S. Karapetis, Sandrine Hiret, Gyula Ostoros, Kaoru Kubota, Jhanelle E. Gray, Luis Paz‐Ares, Javier de Castro, Corinne Faivre‐Finn, Martin Reck, Johan Vansteenkiste, David R. Spigel, Catherine Wadsworth, Giovanni Melillo, Maria Taboada, Phillip A. Dennis, Mustafa Özgüroğlu
New England Journal of Medicine. 20182,828 CitationsOPEN ACCESS
Consensus statement on the pathology of IgG4-related disease
Vikram Deshpande, Yoh Zen, John K. C. Chan, Eunhee E Yi, Yasuharu Sato, Tadashi Yoshino, Günter Klöppel, J.G. Heathcote, Arezou Khosroshahi, Judith A. Ferry, Rob C. Aalberse, Donald B. Bloch, William R. Brugge, Adrian C Bateman, Mollie N. Carruthers, Suresh T. Chari, Wah Cheuk, Lynn D. Cornell, Carlos Fernández‐del Castillo, David G. Forcione, Daniel L. Hamilos, Terumi Kamisawa, Satomi Kasashima, Shigeyuki Kawa, Mitsuhiro Kawano, Gregory Y. Lauwers, Yasufumi Masaki, Yasuni Nakanuma, Kenji Notohara, Kazuichi Okazaki, Ji Kon Ryu, Takako Saeki, Dushyant V. Sahani, Thomas C. Smyrk, James R. Stone, Masayuki Takahira, George Webster, Motohisa Yamamoto, Giuseppe Zamboni, Hisanori Umehara, John H. Stone
Modern Pathology. 20122,595 CitationsOPEN ACCESS

How much of the research on Kansai Medical University is open access?

ScholarIQopen access share
67%OPEN ACCESS
Gold
0%
Green
8%
Hybrid
0%
Bronze
58%
Closed
33%

Related on ScholarIQ

470M+ articles · 14-day free trial